1984 Ventures is an early-stage venture capital firm that primarily focuses on pre-seed and seed investments in innovative startups. They target companies leveraging software to disrupt industries, with a particular interest in sectors such as SaaS, B2B, healthcare, infrastructure/open source, Banking and Finance, and DeepTech. The firm emphasizes supporting founders with strong engineering cultures and provides hands-on assistance beyond capital to prepare companies for successful Series A rounds.
Deal activity increased 33% year-over-year (4 deals in the last 12 months). Their most common stage is seed (40% of deals). Average disclosed round size is $18.4M (across 35 rounds with reported amounts).
Portfolio
35
Fund Size
$250M
Top Stage
Seed
Last 12 Mo
4
Portfolio Breakdown
Stage Distribution
Sector Distribution
Investment Activity
Portfolio
| Company | Round | Amount | Date |
|---|---|---|---|
 Oasys Health | Seed | $4.6M | Jan 2026 |
 Stuut Technologies | Series A | $29.5M | Nov 2025 |
 Cline | Series A | $32M | Jul 2025 |
 Clarium | Series A | $27M | May 2025 |
 Tandem | Seed | $6.1M | Feb 2025 |
 Revv | Series B | $20M | Nov 2024 |
 Fay | Series B | $25M | May 2024 |
 Collaborative Robotics | Series B | $100M | Apr 2024 |
 VectorShift | Seed | $3M | Feb 2024 |
 Cleva | Pre-Seed | $1.5M | Jan 2024 |
 Guac | Seed | $2.3M | Dec 2023 |
 Syrup | Series A | $17.5M | Dec 2023 |
| Revv | Seed | $2.1M | Oct 2023 |
| TTeachMe.To | Seed | $2M | Sep 2023 |
| Collaborative Robotics | Series A | $30M | Jul 2023 |
 Oxygen | Series B | $20M | Feb 2023 |
 Kyte | Series B | $60M | Nov 2022 |
 Relevize | Seed | $6M | Oct 2022 |
 Latchel | Series A | $16.7M | Jul 2022 |
| SSyrup Tech Inc. | Seed | $6.3M | Jun 2022 |
| Collaborative Robotics | Seed | $10M | Jun 2022 |
 House Rx | Series A | $25M | Mar 2022 |
 DeepScribe | Series A | $30M | Jan 2022 |
 ShipBlu | Seed | $2.4M | Oct 2021 |
 Convex | Series B | $39M | Oct 2021 |
Top Co-Investors
Last updated: 15 April 2026